[Federal Register Volume 68, Number 63 (Wednesday, April 2, 2003)]
[Notices]
[Pages 16091-16092]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-7827]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 9, 2003, Rhodes 
Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made 
application by renewal and by letters dated January 28, 2003 and 
February 26, 2003, to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic class of Schedule I 
and II controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Thebaine (9333)............................  II
Methylphenidate (1724).....................  II
Tetrahydrocannabinols (7370)...............  I
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Fentanyl (9801)............................  II
Noroxymorphone (9668)......................  II
Dihydrocodeine (9120)......................  II
------------------------------------------------------------------------

    The firm plans to produce bulk products for conversion and 
distribution to its customers.
    Any other such applicant and any person who is presently registered 
with

[[Page 16092]]

DEA to manufacture such substances may file comments or objections to 
the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Drug Operations Section, Domestic Drug 
Unit (ODOD) and must be filed no later than 60 days from publication.

    Dated: March 14, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-7827 Filed 4-1-03; 8:45 am]
BILLING CODE 4410-09-M